Xilio Therapeutics, Inc. announced plans to reprioritize its resources, including a workforce reduction. Undertake efforts to further reduce its expenses and streamline its operations, including a reduction in headcount of 15 employees, representing approximately 21% of the company?s current workforce. In connection with the workforce reduction, Xilio expects to incur one-time costs of approximately $1.0 million, primarily related to cash expenditures for severance and benefits continuation.

The company estimates that the workforce reduction will be substantially completed in the first half of 2024.